The FDA today issued a notice classifying a recall of Abbott (NYSE:ABT) FreeStyle Libre readers as Class I, the most serious kind. Earlier this week, Abbott initiated a voluntary medical device correction to emphasize instructions for FreeStyle Libre continuous glucose monitor (CGM) readers. The company said it received a limited number of global reports (0.0017%) from […]
Technology
Smart Meter announces free program to reduce diabetes care costs
Smart Meter today announced its iGlucose Challenge to healthcare payors and providers in the U.S. to improve care costs for people with diabetes. Tampa, Florida-based Smart Meter aims to reduce the cost of care and lower A1C for people managing diabetes. The company, which provides remote patient monitoring solutions, offers this as a no-risk, performance-based […]
Bigfoot Biomedical acquires insulin titration algorithm developed at McGill University
Bigfoot Biomedical announced today that it acquired a reinforcement learning algorithm for insulin titration from McGill University. Developers at McGill designed the algorithm to observe how well people with insulin-requiring diabetes respond to a particular dose. It provides a recommended adjustment based on the body’s response. Milpitas, California-based Bigfoot said the developers built the algorithm […]
Better Therapeutics hopes FDA nod for diabetes digital therapeutic comes in 2023
Better Therapeutics (Nasdaq:BTTX) shares ticked up on fourth-quarter results and projections for its flagship product in 2023. The company’s quarterly results come on the heels of a 35% headcount reduction. Better Therapeutics said the headcount cut comes as part of a cost reduction initiative. It aims to improve its cash runway and “focus on the long-term success […]
11 diabetes tech startups you need to know
The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps and the artificial pancreas, we’ve seen a lot. Companies are looking for all kinds of ways to make their mark in the world of diabetes. Newer offerings include digital health, software, coaching and more. For companies still in their […]
New Philips Virtual Care Management portfolio extends to diabetes
Philips (NYSE:PHG) announced today that it debuted its Philips Virtual Care Management portfolio of flexible solutions and services. The Amsterdam-based medtech giant aims to help health systems, providers, payers and employers connect with patients from virtually anywhere. It designed the portfolio to reduce pressure on hospital staff by decreasing emergency department visits and reducing care […]
ViCentra now offers Kaleido insulin pump in the Netherlands
ViCentra recently announced that it made its Kaleido insulin pump system available for users in the Netherlands. Utrecht, the Netherlands-based ViCentra designed its insulin pump system as a small, light and accurate platform. The company says the system “lets people with diabetes live life on their own terms.” Kaleido features pulse technology that provides continuous […]
This implantable drug delivery system is self-powered
Researchers at Shirley Ryan AbilityLab and Northwestern University developed technology that uses external light sources to trigger drug delivery. Yamin Zhang and Dr. Colin Franz of Shirley Ryan and John Rogers of Northwestern led the research team. They say their technology represents the first implantable drug delivery system triggered by external light sources. These light […]
Access in parts of Canada expands for Dexcom G6 CGM
Dexcom (Nasdaq:DXCM) announced that all people with type 1 and type 2 diabetes in Manitoba, Canada, meet eligibility criteria for its G6 CGM. As of the company’s announcement, Manitoba is the only province in Canada that does not require an application for coverage preapproval. That means improved access for patients and a reduced workload for […]
Stevanato Group, Thermo Fisher to bring on-body drug delivery system to market
Stevanato Group (NYSE:STVN) today announced a collaboration with Thermo Fisher Scientific (NYSE:TMO) on drug delivery technology. The partnership aims to bring a fully integrated, on-body delivery system platform for subcutaneous administration to market. Stevanato Group said in a news release that the planned device will be semi-reusable and provide micro-precision basal doses and full-content bolus […]
